SCHEMBL6175223

SCHEMBL6175223

CC(C)[C@@]1(Cc2ccnc3ccccc23)NC(=O)N(c2ccc(SC(F)(F)F)cc2)C1=O

nearest known ligand 0.43

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 18/20 0.43
AR P10275 1/20 0.40
NTRK1 P04629 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6175028 0.86 IGF1R (0.45) IGF1RARNTRK1
SCHEMBL6173427 0.86 IGF1R (0.45) IGF1RARNTRK1
SCHEMBL6172394 0.84 IGF1R (0.62) IGF1RAR
Trifluoroacetic Acid SCHEMBL17558379 0.82 IGF1R (0.42) IGF1RARNTRK1
SCHEMBL6172123 0.79 IGF1R (0.38) IGF1RARNTRK1
Trifluoroacetic Acid SCHEMBL17558337 0.77 IGF1R (0.37) IGF1RARNTRK1
SCHEMBL2938760 0.76 IGF1R (0.72) IGF1R
SCHEMBL17558435 0.76 IGF1R (0.36) IGF1RARNTRK1
SCHEMBL6174389 0.75 IGF1R (0.42) IGF1R
SCHEMBL6173605 0.74 IGF1R (0.45) IGF1RAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed